Skip to main content
Top
Published in: Virchows Archiv 3/2015

01-03-2015 | Original Article

Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma

Authors: Joshua I. Warrick, Daniel H. Hovelson, Anmol Amin, Chia-Jen Liu, Andi K. Cani, Andrew S. McDaniel, Venkata Yadati, Michael J. Quist, Alon Z. Weizer, J. Chad Brenner, Felix Y. Feng, Rohit Mehra, Catherine S. Grasso, Scott A. Tomlins

Published in: Virchows Archiv | Issue 3/2015

Login to get access

Abstract

Although multifocal tumors and non-invasive/invasive components are commonly encountered in surgical pathology, their genetic relationship is often poorly characterized. We used next-generation sequencing (NGS) to characterize somatic alterations in a patient with five spatially distinct, high-grade papillary urothelial carcinomas (UCs), with one tumor harboring an underlying invasive component. NGS of 409 cancer-related genes was performed on DNA isolated from formalin-fixed paraffin-embedded (FFPE) blocks representing each papillary tumor (n = 5), the invasive component of one tumor, and matched normal tissue. We identified nine unique non-synonymous somatic mutations across the six UC samples, including five present in each carcinoma sample, consistent with clonal origin and limited intertumoral heterogeneity. Copy number and loss of heterogeneity (LOH) profiles were similar in all six carcinomas; however, the invasive carcinoma component uniquely showed focal CDKN2A loss and chromosome 9 LOH and did not harbor gains of chromosomes 5p or X that were present in the other tumor samples. Phylogenetic analysis supported the invasive component arising from a shared progenitor prior to the outgrowth of cells in the non-invasive tumors. Results were extended to three additional cases of upper tract UC with paired non-invasive/invasive components, which identified driving alterations exclusive to both non-invasive and invasive components. Lastly, we performed targeted RNA sequencing (RNAseq) using a custom bladder cancer panel, which confirmed gene expression signature differences between paired non-invasive/invasive components. The results and approaches presented here may be useful in understanding the clonal relationships in multifocal cancers or paired non-invasive/invasive components from routine FFPE specimens.
Appendix
Available only for authorised users
Literature
1.
go back to reference Babjuk M, Oosterlinck W, Sylvester R et al (2011) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 59:997–1008CrossRefPubMed Babjuk M, Oosterlinck W, Sylvester R et al (2011) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 59:997–1008CrossRefPubMed
2.
go back to reference Xylinas E, Rink M, Margulis V et al (2012) Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence. Eur Urol 61:1069–1070CrossRefPubMed Xylinas E, Rink M, Margulis V et al (2012) Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence. Eur Urol 61:1069–1070CrossRefPubMed
3.
go back to reference Lin HH, Ke HL, Wu WJ, Lee YH, Chang LL (2012) Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection. Urol Oncol 30:177–181CrossRefPubMed Lin HH, Ke HL, Wu WJ, Lee YH, Chang LL (2012) Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection. Urol Oncol 30:177–181CrossRefPubMed
4.
go back to reference Bornman DM, Mathew S, Alsruhe J, Herman JG, Gabrielson E (2001) Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. Am J Pathol 159:831–835CrossRefPubMedCentralPubMed Bornman DM, Mathew S, Alsruhe J, Herman JG, Gabrielson E (2001) Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. Am J Pathol 159:831–835CrossRefPubMedCentralPubMed
5.
go back to reference Yamamoto S, Romanenko A, Wei M et al (1999) Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident. Cancer Res 59:3606–3609PubMed Yamamoto S, Romanenko A, Wei M et al (1999) Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident. Cancer Res 59:3606–3609PubMed
6.
go back to reference Denzinger S, Mohren K, Knuechel R et al (2006) Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses. Hum Pathol 37:143–151CrossRefPubMed Denzinger S, Mohren K, Knuechel R et al (2006) Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses. Hum Pathol 37:143–151CrossRefPubMed
7.
go back to reference Louhelainen J, Wijkstrom H, Hemminki K (2000) Allelic losses demonstrate monoclonality of multifocal bladder tumors. Int J Cancer 87:522–527CrossRefPubMed Louhelainen J, Wijkstrom H, Hemminki K (2000) Allelic losses demonstrate monoclonality of multifocal bladder tumors. Int J Cancer 87:522–527CrossRefPubMed
8.
go back to reference Simon R, Eltze E, Schafer KL et al (2001) Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Res 61:355–362PubMed Simon R, Eltze E, Schafer KL et al (2001) Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Res 61:355–362PubMed
9.
go back to reference Stoehr R, Knuechel R, Boecker J et al (2002) Histologic-genetic mapping by allele-specific PCR reveals intraurothelial spread of p53 mutant tumor clones. Lab Invest 82:1553–1561CrossRefPubMed Stoehr R, Knuechel R, Boecker J et al (2002) Histologic-genetic mapping by allele-specific PCR reveals intraurothelial spread of p53 mutant tumor clones. Lab Invest 82:1553–1561CrossRefPubMed
10.
go back to reference Stoehr R, Hartmann A, Hiendlmeyer E, Murle K, Wieland W, Knuechel R (2000) Oligoclonality of early lesions of the urothelium as determined by microdissection-supported genetic analysis. Pathobiology 68:165–172CrossRefPubMed Stoehr R, Hartmann A, Hiendlmeyer E, Murle K, Wieland W, Knuechel R (2000) Oligoclonality of early lesions of the urothelium as determined by microdissection-supported genetic analysis. Pathobiology 68:165–172CrossRefPubMed
11.
go back to reference Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507:315–22 Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507:315–22
12.
go back to reference Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T, Cordon-Cardo C (2010) Molecular pathways of urothelial development and bladder tumorigenesis. Urol Oncol 28:401–408CrossRefPubMed Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T, Cordon-Cardo C (2010) Molecular pathways of urothelial development and bladder tumorigenesis. Urol Oncol 28:401–408CrossRefPubMed
13.
go back to reference Netto GJ (2012) Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? Nat Rev Urol 9:41–51CrossRef Netto GJ (2012) Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? Nat Rev Urol 9:41–51CrossRef
14.
go back to reference Sidrandsky DF, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B (1992) Clonal origin of bladder cancer. N Engl J Med 326:737–740CrossRef Sidrandsky DF, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B (1992) Clonal origin of bladder cancer. N Engl J Med 326:737–740CrossRef
15.
go back to reference Gerlinger M, Horswell S, Larkin J et al (2014) Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet 46:225–23CrossRefPubMed Gerlinger M, Horswell S, Larkin J et al (2014) Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet 46:225–23CrossRefPubMed
16.
go back to reference Gerlinger M, Rowan AJ, Horswell S et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892CrossRefPubMed Gerlinger M, Rowan AJ, Horswell S et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892CrossRefPubMed
17.
go back to reference Nordentoft IL P, Birkenkamp-Demtroder K, Shumansky K, Vang S, Hornshoj H, Juul M, Villesen P, Hedegaard J, Roth A, Thorsen K, Hoyer S, Borre M, Reinert T, Fristrup N, Dyrskjot L, Shah S, Pedersen JS, Orntoft TF (2014) Mutational context and diverse clonal developments in early and late bladder cancer. Cell Rep 7:1649–1663CrossRef Nordentoft IL P, Birkenkamp-Demtroder K, Shumansky K, Vang S, Hornshoj H, Juul M, Villesen P, Hedegaard J, Roth A, Thorsen K, Hoyer S, Borre M, Reinert T, Fristrup N, Dyrskjot L, Shah S, Pedersen JS, Orntoft TF (2014) Mutational context and diverse clonal developments in early and late bladder cancer. Cell Rep 7:1649–1663CrossRef
19.
go back to reference Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38:3 Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38:3
20.
go back to reference Grasso C, Butler T, Rhodes K, et al. (2014) Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data. J Mol Diagn. (in press) Grasso C, Butler T, Rhodes K, et al. (2014) Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data. J Mol Diagn. (in press)
21.
go back to reference Choi W, Porten S, Kim S et al (2014) Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25:152–165CrossRefPubMedCentralPubMed Choi W, Porten S, Kim S et al (2014) Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25:152–165CrossRefPubMedCentralPubMed
22.
go back to reference Damrauer JS, Hoadley KA, Chism DD et al (2014) Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc Natl Acad Sci U S A 111:3110–3115CrossRefPubMedCentralPubMed Damrauer JS, Hoadley KA, Chism DD et al (2014) Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc Natl Acad Sci U S A 111:3110–3115CrossRefPubMedCentralPubMed
23.
go back to reference Balbas-Martinez C, Sagrera A, Carrillo-de-Santa-Pau E et al (2013) Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. Nat Genet 45:1464–1469CrossRefPubMed Balbas-Martinez C, Sagrera A, Carrillo-de-Santa-Pau E et al (2013) Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. Nat Genet 45:1464–1469CrossRefPubMed
24.
go back to reference Guo G, Sun X, Chen C et al (2013) Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet 45:1459–1463CrossRefPubMed Guo G, Sun X, Chen C et al (2013) Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet 45:1459–1463CrossRefPubMed
25.
go back to reference Iyer G, Al-Ahmadie H, Schultz N et al (2013) Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer. J Clin Oncol 31:3133–3140CrossRefPubMedCentralPubMed Iyer G, Al-Ahmadie H, Schultz N et al (2013) Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer. J Clin Oncol 31:3133–3140CrossRefPubMedCentralPubMed
26.
go back to reference Kompier LC, Lurkin I, van der Aa MN, van Rhijn BW, van der Kwast TH, Zwarthoff EC (2010) FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy. PLoS One 5:e13821CrossRefPubMedCentralPubMed Kompier LC, Lurkin I, van der Aa MN, van Rhijn BW, van der Kwast TH, Zwarthoff EC (2010) FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy. PLoS One 5:e13821CrossRefPubMedCentralPubMed
27.
go back to reference Rebouissou S, Herault A, Letouze E et al (2012) CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma. J Pathol 227:315–324 Rebouissou S, Herault A, Letouze E et al (2012) CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma. J Pathol 227:315–324
28.
go back to reference Greulich H, Kaplan B, Mertins P et al (2012) Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2. Proc Natl Acad Sci U S A 109:14476–14481CrossRefPubMedCentralPubMed Greulich H, Kaplan B, Mertins P et al (2012) Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2. Proc Natl Acad Sci U S A 109:14476–14481CrossRefPubMedCentralPubMed
29.
go back to reference Ross JS, Wang K, Gay LM et al (2014) A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinoma. Clin Cancer Res 20:68–75CrossRefPubMed Ross JS, Wang K, Gay LM et al (2014) A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinoma. Clin Cancer Res 20:68–75CrossRefPubMed
Metadata
Title
Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma
Authors
Joshua I. Warrick
Daniel H. Hovelson
Anmol Amin
Chia-Jen Liu
Andi K. Cani
Andrew S. McDaniel
Venkata Yadati
Michael J. Quist
Alon Z. Weizer
J. Chad Brenner
Felix Y. Feng
Rohit Mehra
Catherine S. Grasso
Scott A. Tomlins
Publication date
01-03-2015
Publisher
Springer Berlin Heidelberg
Published in
Virchows Archiv / Issue 3/2015
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-014-1699-y

Other articles of this Issue 3/2015

Virchows Archiv 3/2015 Go to the issue

Editorial

In this issue